BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//UW Department of Psychiatry - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.psychiatry.wisc.edu
X-WR-CALDESC:Events for UW Department of Psychiatry
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20180311T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20181104T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20190310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20191103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20200308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20201101T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20210314T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20211107T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20220313T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20221106T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20210730T120000
DTEND;TZID=America/Chicago:20210730T131500
DTSTAMP:20260522T042933
CREATED:20200908T200642Z
LAST-MODIFIED:20210715T162707Z
UID:5808-1627646400-1627650900@www.psychiatry.wisc.edu
SUMMARY:UW Psychiatry Grand Rounds | Angela Haeny\, PhD
DESCRIPTION:  \nUW Psychiatry Grand Rounds | Angela Haeny\, PhD\nApplying a Social Justice Lens to Substance Use Research \n \nAbstract: \nThe objective of this talk is to discuss approaches for applying social justice to substance use research with a focus on racially/ethnically diverse populations. Specifically\, the approaches that will be discussed include attending to measurement issues\, constructs of particular salience to racially/ethnically diverse populations\, and community engagement. Many of the examples provided will be based on my research aimed at improving substance use treatment retention\, outcomes\, and satisfaction among Black adults. \n\nLearning Objectives: \n1. Learn approaches for applying social justice to clinical care and research\n2. Identify constructs salient to People of Color\n3. Describe considerations for measures used in clinical care and research and evidence supporting their validity in racially/ethnically diverse populations \n\nAbout the Speaker:\nDr. Angela Haeny is an Assistant Professor of Psychiatry at Yale School of Medicine and a licensed Clinical Psychologist with specialty in substance use disorders. She received her undergraduate degree in Psychology and Addiction Studies from the University of Minnesota\, received her doctorate from the University of Missouri\, completed her internship in Clinical and Community Psychology at Yale School of Medicine\, and completed a NIDA T32 postdoctoral fellowship through the Division of Prevention and Community Research at Yale School of Medicine. Dr. Haeny is committed to eliminating racial disparities and enhancing diversity\, equity\, and inclusion\, which cuts across all aspects of her work. Her research involves addressing race-related stress to improve drug and alcohol treatment outcomes among Black adults. \n\nReading List:  \n\nThe Need for Shared Nomenclature on Racism and Related Terminology in Psychology\nThe association between racial and socioeconomic discrimination and two stages of alcohol use in blacks\nMeasurement invariance of the Barratt Impulsiveness Scale across black and white adults with cocaine use disorder\n\n\n\nAccreditation Statement \nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statements \nAmerican Medical Association (AMA) \nThe University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. \nAmerican Nurses Credentialing Center (ANCC) \nThe University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.0 ANCC contact hours. \nAmerican Psychological Association (APA) \n \nContinuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs. \nContinuing Education Units\nThe University of Wisconsin–Madison ICEP\, as a member of the University Professional & Continuing Education Association (UPCEA)\, authorizes this program for 0.125 continuing education units (CEUs) or 1.25 hours.
URL:https://www.psychiatry.wisc.edu/event/uw-psychiatry-grand-rounds-speaker-tba-2/
LOCATION:Webex
CATEGORIES:CME,Grand Rounds
ORGANIZER;CN="Jennifer Noll":MAILTO:jnoll3@wisc.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20210528T120000
DTEND;TZID=America/Chicago:20210528T131500
DTSTAMP:20260522T042933
CREATED:20200908T200813Z
LAST-MODIFIED:20210112T202905Z
UID:5810-1622203200-1622207700@www.psychiatry.wisc.edu
SUMMARY:UW Psychiatry Grand Rounds | Speaker TBA
DESCRIPTION:Speaker TBA | UW Psychiatry Grand Rounds\nTitle TBA \nLearning Objectives: \n\n__\n__\n__\n\n\nAbout the Speaker: \n  \n\nReading List:  \n\n__\n__\n__\n\n\n\nAccreditation Statement \nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statements \nAmerican Medical Association (AMA) \nThe University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. \nAmerican Nurses Credentialing Center (ANCC) \nThe University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.25 ANCC contact hours. \nAmerican Psychological Association (APA) \n \nContinuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs. \nContinuing Education Units\nThe University of Wisconsin–Madison ICEP\, as a member of the University Professional & Continuing Education Association (UPCEA)\, authorizes this program for 0.125 continuing education units (CEUs) or 1.25 hours.
URL:https://www.psychiatry.wisc.edu/event/uw-psychiatry-grand-rounds-speaker-tba-3/
LOCATION:Webex
CATEGORIES:CME,Grand Rounds
ORGANIZER;CN="Jennifer Noll":MAILTO:jnoll3@wisc.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20210226T120000
DTEND;TZID=America/Chicago:20210226T131500
DTSTAMP:20260522T042933
CREATED:20210112T203017Z
LAST-MODIFIED:20210216T204313Z
UID:6556-1614340800-1614345300@www.psychiatry.wisc.edu
SUMMARY:UW Psychiatry Grand Rounds | Josh Cisler\, PhD
DESCRIPTION:Learning and Decision-making in PTSD\nJosh Cisler\, Ph.D.\nAssociate Professor of Psychiatry\nUniversity of Wisconsin-Madison\n  \n\nTalk Description: \nThis presentation will discuss emerging research aimed at characterizing a dynamic model of psychopathology following trauma that emphasizes learning from and interacting with the environment. This presentation will include discussion of new methods for enhancing extinction learning in PTSD as a model for increasing exposure therapy efficacy. There are no financial conflicts of interest to disclose. \nLearning Objectives: \n\nOutline new models for understanding the psychopathology of PTSD\nIdentify new approaches for enhancing extinction learning in PTSD across the healthcare team\n\n\nAbout the Speaker: \nDr. Josh Cisler received a doctorate in clinical psychology from the University of Arkansas\, Fayetteville in 2010. He completed a clinical internship at the Medical University of South Carolina through the National Crime Victim Research and Treatment Center\, where his research focused on understanding risk factors for psychopathology following trauma\, with a particular focus on assaultive events (e.g.\, physical and sexual assault). He then completed a postdoctoral fellowship in the Brain Imaging Research Center at the University of Arkansas for Medical Sciences\, where he received training in fMRI methodology and advanced computational approaches to imaging analysis. He was on the faculty of the Brain Imaging Research Center from 2012-2016\, and joined the faculty of the Department of Psychiatry at the University of Wisconsin Madison in 2016. \n\nWebEx Information:  \nhttps://uwmadison.webex.com/uwmadison/onstage/g.php?MTID=e22445f02d3c807b9b49343fa8d70cebf \nEvent number:	120 701 8384\nEvent password:	CISLER (247537 from phones)\nVideo Address:	1207018384@uwmadison.webex.com\nYou can also dial 173.243.2.68 and enter your meeting number.\nAudio conference: 	US Toll\n+1-415-655-0001\nAccess code: 120 701 8384 \n\nAccreditation Statement \nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statements \nAmerican Medical Association (AMA) \nThe University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. \nAmerican Nurses Credentialing Center (ANCC) \nThe University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.25 ANCC contact hours. \nAmerican Psychological Association (APA) \n \nContinuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs. \nContinuing Education Units\nThe University of Wisconsin–Madison ICEP\, as a member of the University Professional & Continuing Education Association (UPCEA)\, authorizes this program for 0.125 continuing education units (CEUs) or 1.25 hours.
URL:https://www.psychiatry.wisc.edu/event/uw-psychiatry-grand-rounds-speaker-tba/
CATEGORIES:CME,Grand Rounds
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20210129T120000
DTEND;TZID=America/Chicago:20210129T131500
DTSTAMP:20260522T042933
CREATED:20200908T200356Z
LAST-MODIFIED:20210127T212805Z
UID:5806-1611921600-1611926100@www.psychiatry.wisc.edu
SUMMARY:Kiki D. Chang\, MD | UW Psychiatry Grand Rounds
DESCRIPTION:Pediatric Bipolar Disorder: Clues for Early Identification and Prevention\n*** Part of the Briskey Family Bipolar Lecture Series *** \nLearning Objectives: \n\nAccurately understand the early presentations of bipolar disorders in youth.\nConsider alternate diagnoses for youth with irritability and mood difficulties\nDiscuss approaches to identifying and treating youth at high risk for bipolar disorder\n\nTalk Description: \nBipolar disorder (BD) is a chronic\, debilitating illness with a lifetime worldwide prevalence of 2.4% and more disability-adjusted life-years lost than major neurological conditions or cancer.  Children with BD have a more severe course of illness with high relapse\, recurrence\, psychosocial impairment\, substance use\, and suicide at twice the rate of attempted suicides when compared to individuals with unipolar depression. Identification and recognition of symptoms that predate BD in youth would aid in early intervention and prevention efforts.  This presentation will discuss the clinical presentation of early and fully developed BD in youth\, and discuss early intervention efforts so far to treat youth with early forms of BD to prevent development of full BD in their lifetime. \n\nAbout the Speaker: \nKiki D. Chang\, MD is a Psychiatrist in private practice in Palo Alto\, CA. He is a former Professor of Psychiatry and Behavioral Sciences at the Stanford University School of Medicine\, Division of Child Psychiatry. He is also former Director of the Pediatric Bipolar Disorders Clinic\, where he specialized in pediatric psychopharmacology and treatment of depression and bipolar disorder in children and adolescents. Dr. Chang also previously directed the Pediatric Psychopharmacology and Advanced Pediatric Psychopharmacology courses at Stanford. \nDr. Chang graduated cum laude from Princeton University and received his M.D. from the Tufts University School of Medicine. He completed his general psychiatry residency at the University of Cincinnati and his child psychiatry fellowship at Stanford University. After a postdoctoral research fellowship\, Dr. Chang joined the Stanford faculty in 1999. \nDr. Chang is the recipient of the Eli Lilly Pilot Research Award from the American Academy of Child and Adolescent Psychiatry\, the Klingenstein Third Generation Foundation Fellowship in Child and Adolescent Depression\, and the 2003 American Psychiatric Association/AstraZeneca Young Minds in Psychiatry Award. He has been the recipient of two NARSAD Young Investigator Awards and has received a 5-year Career Development Award from the National Institutes of Health. \nAs Director of the Pediatric Bipolar Disorders Program\, Dr. Chang conducts research into various facets of bipolar disorder. He is currently conducting phenomenologic\, biologic\, pharmacologic\, and genetic studies of bipolar disorder in adults and children. These studies include brain imaging (MRI\, MRS\, fMRI) and medication trials. He is particularly interested in detecting prodromal bipolar disorder in children who might then be treated to prevent the development of full bipolar disorder. To do this\, he has been studying children of parents with bipolar disorder who are at high risk for developing the disorder themselves. \nDr. Chang is the author of numerous papers and book chapters regarding bipolar disorder and pediatric psychopharmacology and has presented widely at national and international scientific conferences and meetings. \nAdditional Information about Kiki Chang\, MD: \nCV: Kiki Chang\, MD \nhttps://www.kikichangmd.com \nhttps://www.gmeded.com/faculty/kiki-d-chang-md \nPBS Interview:\nhttps://www.pbs.org/wgbh/pages/frontline/medicatedchild/interviews/chang.html \n\nReading List:  \n\nFamily-focused Therapy for Symptomatic Youths at High Risk for Bipolar Disorder\nA Pharmacologic Algorithm for Youth Who Are at High Risk for Bipolar Disorder\n\n\nWebex Information:  \nEvent number: 120 312 6463\nEvent password: Chang (24264 from phones) \nTo join the online event: \n1. Go to https://uwmadison.webex.com/uwmadison/onstage/g.php?d=1203126463&t=a&EA=jnonnynonny%40yahoo.com&ET=SDJTSwAAAAS_mOr5901AzBJKkuWD2eLqQjfr40laRqyuiAD5Mxkgmw2&ETR=SDJTSwAAAAQ7P4RdlPM8-9tkwIdpFv-yDLnKrQtHNf1EofQpZR2ouA2&RT=MiM3&p \n2. Click “Join Now”. \nJoin the audio conference only\nUS Toll: +1-415-655-0001\nAccess code: 120 312 6463 \nFor assistance:\nYou can contact JENNIFER NOLL at:\njnoll3@wisc.edu \n\nAccreditation Statement \nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statements \nAmerican Medical Association (AMA) \nThe University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. \nAmerican Nurses Credentialing Center (ANCC) \nThe University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.0 ANCC contact hours. \nAmerican Psychological Association (APA) \n \nContinuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs. \nContinuing Education Units\nThe University of Wisconsin–Madison ICEP\, as a member of the University Professional & Continuing Education Association (UPCEA)\, authorizes this program for 0.125 continuing education units (CEUs) or 1.25 hours.
URL:https://www.psychiatry.wisc.edu/event/kiki-chang-md-uw-psychiatry-grand-rounds/
LOCATION:Webex
CATEGORIES:CME,Grand Rounds
ORGANIZER;CN="Jennifer Noll":MAILTO:jnoll3@wisc.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20201113T120000
DTEND;TZID=America/Chicago:20201113T131500
DTSTAMP:20260522T042933
CREATED:20191204T191241Z
LAST-MODIFIED:20201105T200509Z
UID:4219-1605268800-1605273300@www.psychiatry.wisc.edu
SUMMARY:Samantha Meltzer-Brody\, MD\, MPH | UW Psychiatry Grand Rounds
DESCRIPTION:  \nINNOVATION IN RESEARCH AND TREATMENT OF PERINATAL DEPRESSION – WHERE ARE WE NOW?\n\n  \nSamantha Meltzer-Brody\, MD\, MPH\nAssad Meymandi Distinguished Professor and Chair\nDirector\, UNC Center for Women’s Mood Disorders\nUNC School of Medicine \n  \nIn this talk\, we will review current innovations in research and treatment of perinatal depression. We will examine the impact of the COVID-19 pandemic and what we can learn from utilization of telepsychiatry to increase access to care.  We will review how research is conducted using smart phones and other mobile devices. We will also discuss new FDA treatments for perinatal depression\, including brexanolone.  Lastly\, we will discuss the health disparities observed and the imperative to develop novel solutions to these complex and longstanding issues. \n\nLearning objectives: \n\nDiscuss the transformation of care using telepsychiatry in the perinatal psychiatry population\nDescribe the genetic contributions to perinatal depression\nDescribe current new treatment approaches for perinatal depression\, including brexanolone\n\nReading List:  \n\nBauer A\, Liu X\, Byrne E\, Sullivan PF\, Wray N\, Agerbo E\, Nyegaard M\, Grove J\, Musliner K\, Ingstrup K\, Johannsen B\, Maegbaek M\, Wang Y\, Nordentoft M\, Mors O\, Børglum A\, Werge T\, Hougaard D\, Mortensen PB\, Munk-Olsen T\, Meltzer-Brody S. Genetic Risk Scores and Postpartum Psychiatric Disorders\, Translational Psychiatry\, 9(1): 288 PMID: 31911347.\n\n\nGuintivano J\, Krohn H\, Lewis C\, Byrne EM\, Henders AK\, Ploner A\, Kirk K\, Martin NG\, Milgrom J\, Wray NR\, Sullivan PF\, Meltzer-Brody S. (2018) PPD ACT app\, an app based Postpartum Depression Genetic Study\, Translational Psychiatry\, Nov 29;8(1):260. doi: 10.1038/s41398-018-0305-5. PMID: 30498212.\nMeltzer-Brody S\, Colquhoun H\, Riesenberg R\, Epperson CN\, MD; Deligiannidis K\, Rubinow D\, Li H\, Sankoh AJ\, Clemson C\, Schacterle A\, Jonas J\, Kanes SJ. (2018) Brexanolone injection in post-partum depression: two multicenter\, double-blind\, randomized placebo-controlled\, phase 3 trials. The Lancet\, Sep 22;392(10152):1058-1070. PMID: 30177236.\n\n\nDr. Samantha Meltzer-Brody\, MD\, MPH\, is the Assad Meymandi Distinguished Professor and Chair of the Department of Psychiatry in the UNC School of Medicine. She also serves as the Director for the UNC Center for Women’s Mood Disorders. \nHer current research efforts are focused primarily on Perinatal Depression and she is currently funded by multiple NIH grants to investigate epidemiologic\, genetic\, and other biomarker models of perinatal depression. She established the international postpartum depression consortium (PACT) and is the co-I of the PPD ACT app\, a smart phone study that is a large international genetic study of postpartum depression and postpartum psychosis. Dr. Meltzer-Brody and colleagues also investigate novel treatment options for depression in perinatal women and she is the academic PI for the brexanolone clinical trials. She also collaborates with colleagues on global health efforts including perinatal mental health in Malawi\, Africa. Dr. Meltzer-Brody has been named one of the “Top 10 Women in Medicine” from the Triangle Business Journal and is the 2016 recipient of the North Carolina Psychiatric Association Eugene Hargrove Award and the 2015 Arnold Kaluzny Distinguished Alumni Award\, from Public Health Leadership Program of the UNC School of Public Health \nShe is also the founder of the Taking Care of Our Own Program\, a resource for UNC School of Medicine and Health Care employees. \n\nWebex Information:  \nhttps://uwmadison.webex.com/uwmadison/onstage/g.php?MTID=ed840073c69e36a0bdf43d26ede248aaf \nEvent number (access code): 120 203 2986\nEvent password: psych (77924 from phones)\nThis event does not require registration. \nJoin the audio conference only: +1-415-655-0001 US Toll \n\nAccreditation Statement \nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statements \nAmerican Medical Association (AMA) \nThe University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. \nAmerican Nurses Credentialing Center (ANCC) \nThe University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.0 ANCC contact hours. \nAmerican Psychological Association (APA) \n \nContinuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs. \nContinuing Education Units\nThe University of Wisconsin–Madison ICEP\, as a member of the University Professional & Continuing Education Association (UPCEA)\, authorizes this program for 0.125 continuing education units (CEUs) or 1.25 hours.
URL:https://www.psychiatry.wisc.edu/event/samantha-meltzer-brody-md-mph-uw-psychiatry-grand-rounds/
LOCATION:Webex
CATEGORIES:CME,Grand Rounds
ATTACH;FMTTYPE=image/jpeg:https://www.psychiatry.wisc.edu/wp-content/uploads/2019/12/Meltzer-Brody-Samantha-2019-e1560955300463.jpg
ORGANIZER;CN="Jennifer Noll":MAILTO:jnoll3@wisc.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20200828T080000
DTEND;TZID=America/Chicago:20200828T091500
DTSTAMP:20260522T042933
CREATED:20191204T185553Z
LAST-MODIFIED:20201001T193114Z
UID:4211-1598601600-1598606100@www.psychiatry.wisc.edu
SUMMARY:Jessi Gold\, MD\, MS | UW Psychiatry Grand Rounds
DESCRIPTION:The Impact of the Pandemic on the Wellness of Healthcare Professionals – and\n#howtohelp\nCovid-19 has had a tremendous impact on healthcare workers\,  from the day-to-day work environment\, to increased risk for infection\, to their mental health. This grand rounds will focus on what we know so far about the mental health of frontline workers prior to and during COVID-19\, and\, how that\, when put into context with what we know from past pandemics\, can allow us to predict the possible  mental health aftermath and risk factors for worsening outcomes. We will talk about the role of the institution in helping prepare for these outcomes as the pandemic becomes a marathon and not a sprint. And\, as Dr. Gold is a very avid twitter user\, this grand rounds will have a specific focus on what individuals can do to advocate for themselves and their colleagues using social media. \n\nLearning objectives: \n\nDescribe what we know so far about the mental health of frontline workers prior to and during COVID-19\nSummarize the literature from past pandemics regarding the possible mental health aftermath and risk factors for worsening outcomes\nDiscuss specifically what individuals can do to advocate for mental health of healthcare workers\, focusing on social media (twitter)\nExamine the role of institutions in promoting long-term change\n\n\nJessica (“Jessi”) Gold\, MD\, MS\, is an Assistant Professor in the Department of Psychiatry at Washington University in Saint Louis School of Medicine. She splits her clinical time between the Habif Health and Wellness Center and outpatient psychiatry at Barnes Jewish Hospital. She also teaches and mentors students and trainees\, and is a regular writer for many media outlets. \nDr. Gold is a graduate of the University of Pennsylvania with a B.A. and M.S in Anthropology and a graduate of the Yale School of Medicine. She completed her residency training in Adult Psychiatry at Stanford University where she served as chief resident from 2017-2018. She has received numerous awards and accolades for her many contributions in the areas of mental health and psychiatry. She is a nationally recognized expert and speaks at national conferences\, is interviewed regularly for news outlets\, and consults for publishing and media. \nDr. Gold’s areas of interest are in college mental health\, women’s mental health and gender equity\, physician wellness\, medical education\, and the between popular media\, stigma\, and psychiatry. While she has published frequently in the more “traditional” methods of research papers and academic publications\, she has also enjoyed teaching about mental health topics and decreasing stigma through writing for popular press outlets. She has been featured in\, among others\, Self\, InStyle\, Glamour\, and the HuffPost. Some of her favorite articles have included writing about Judge Aquilina’s handling of the Larry Nassar case and its importance for survivors\, educating about how to prepare for psychotherapy\, and writing first person accounts of sexual harassment in healthcare for the InStyle launch of TIME’S UP Healthcare. Through her advocacy\, she has forged connections with other inspirational women in medicine that led to many collaborations on popular media\, from interviews\, to podcasts\, to articles. Two such examples include her interview of New York Time’s Best Selling Author\, Dr. Jen Gunter\, about her book for InStyle\, and writing a piece on the illusory truth effect in the false link between gun violence and mental illness for TIME with Dr. Megan Ranney. It also led to the formation of TIME’S UP Healthcare\, for which she serves on the steering committee and is a founding member. \nIn addition to her writing\, Dr. Gold has presented on media as a tool for advocacy\, leadership\, and a way to combat misinformation nationally. She is very active on social media\, particularly twitter (@drjessigold)\, and was named one of Medscape’s top 20 physician influencers on social media in 2019. She believes in using this medium to connect with and educate her patients on issues surrounding psychiatry and other mental health topics and to put a face to psychiatry that can help destigmatize and humanize the field. \n\nAccreditation Statement \nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statements \nAmerican Medical Association (AMA) \nThe University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. \nAmerican Nurses Credentialing Center (ANCC) \nThe University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.0 ANCC contact hours. \nAmerican Psychological Association (APA) \n \nContinuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs. \nContinuing Education Units\nThe University of Wisconsin–Madison ICEP\, as a member of the University Professional & Continuing Education Association (UPCEA)\, authorizes this program for 0.125 continuing education units (CEUs) or 1.25 hours. \n\nWebEx Info\nEvent Address for Attendees:\nhttps://uwmadison.webex.com/uwmadison/onstage/g.php?MTID=eeddb5c2589a58b99a5f2773b7bdad85a\n \nEvent Number: 120 750 7873\nEvent Password : ijMP7MYW3M8 (45677699 from phones)\nVideo Address: 1207507873@uwmadison.webex.com\nYou can also dial 173.243.2.68 and enter your meeting number.\nAudio Conference:  +1-415-655-0001 Access code: 120 750 7873
URL:https://www.psychiatry.wisc.edu/event/speaker-tba-uw-psychiatry-grand-rounds/
LOCATION:Webex
CATEGORIES:CME,Grand Rounds
ATTACH;FMTTYPE=image/jpeg:https://www.psychiatry.wisc.edu/wp-content/uploads/2019/12/Jessica-Gold-hdshot.jpg
ORGANIZER;CN="Jennifer Noll":MAILTO:jnoll3@wisc.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20200131T080000
DTEND;TZID=America/Chicago:20200131T090000
DTSTAMP:20260522T042933
CREATED:20191204T183546Z
LAST-MODIFIED:20200107T200235Z
UID:4202-1580457600-1580461200@www.psychiatry.wisc.edu
SUMMARY:Megan Moreno\, MD\, MSED\, MPH | UW Psychiatry Grand Rounds
DESCRIPTION:Social Media and Adolescent Mental Health\nMegan Moreno\, MD\, MSED\, MPH \nAcademic Division Chief of General Pediatrics and Adolescent Medicine Division\nVice Chair of Digital Health\nPrincipal Investigator\, SMAHRT\nDepartment of Pediatrics\nUniversity of Wisconsin-Madison \nLearning objectives: \n\nUnderstand the current state of the field regarding associations between social media and adolescent mental health\nLearn two measurement approaches in assessing social media use\nUnderstand proposed mechanisms for the relationship between social media and adolescent mental health\nLearn about several current national efforts to improve adolescent mental health and technology use\nConsider how to approach social media use with patients\n\n\nDr. Megan Moreno\, MD\, MSEd\, MPH is the principal investigator (PI) of the Social Media and Adolescent Health Research Team (SMAHRT). Her research team is within the Department of Pediatrics at the University of Wisconsin-Madison. Dr. Moreno is the Academic Division Chief of General Pediatrics and Adolescent Medicine Division\, and Vice Chair of Digital Health in the Department of Pediatrics. She is a Professor of Pediatrics and Adjunct Professor of Educational Psychology at the University of Wisconsin-Madison. \nDr. Moreno received her MD degree from George Washington University School of Medicine. She completed a residency in Pediatrics at the University of Wisconsin-Madison\, during that time she also completed a Masters Degree in Education. She completed a fellowship in Adolescent Medicine at the University of Washington\, during that time she also completed a Masters Degree in Public Health. \n  \n\n \nAccreditation Statement \nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statement: \nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Wisconsin–Madison ICEP\, as a member of the University Professional & Continuing Education Association (UPCEA)\, authorizes this program for 0.1 CEUs or 1.0 hour.
URL:https://www.psychiatry.wisc.edu/event/megan-moreno-md-msed-mph-uw-psychiatry-grand-rounds/
LOCATION:Webex
CATEGORIES:CME,Grand Rounds
ATTACH;FMTTYPE=image/png:https://www.psychiatry.wisc.edu/wp-content/uploads/2019/12/Dr.-Megan-Moreno-768x512.png
ORGANIZER;CN="Jennifer Noll":MAILTO:jnoll3@wisc.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20191115T120000
DTEND;TZID=America/Chicago:20191115T131500
DTSTAMP:20260522T042933
CREATED:20190215T214815Z
LAST-MODIFIED:20191009T190329Z
UID:3517-1573819200-1573823700@www.psychiatry.wisc.edu
SUMMARY:Karen J. Parker\, PhD | UW Psychiatry Grand Rounds
DESCRIPTION:Advances in Detecting and Treating Autism\nKaren J. Parker\, PhD\nAssociate Professor\nDirector\, Social Neurosciences Research Program\nDepartment of Psychiatry and Behavioral Sciences\nStanford University School of Medicine \nReading List: \n\nCerebrospinal Fluid Vasopressin and Symptom Severity in Children with Autism\nA randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism\nArginine vasopressin in cerebrospinal fluid is a marker of sociality in nonhuman primates\nEarly Predictors of Impaired Social Functioning in Male Rhesus Macaques\n\n\nDr. Parker is an Associate Professor of Psychiatry and Behavioral Sciences at Stanford University where she directs the Social Neurosciences Research Program. Dr. Parker’s research expertise is the biology of social functioning\, with a particular interest in oxytocin and vasopressin signaling pathways. Her preclinical research program focuses on developing novel animal models of social impairments; her clinical research program encompasses biomarker discovery and therapeutic testing in patients with autism and other brain disorders. \nDr. Parker received her undergraduate and graduate degrees from the University of Michigan and completed postdoctoral training at Stanford University. Dr. Parker joined the Stanford faculty in 2007. She is an Affiliate Scientist at the California National Primate Research Center\, a Member of the American College of Neuropsychopharmacology\, and a Kavli Fellow of the US National Academy of Sciences. Dr. Parker’s research program has been supported by multiple funding agencies including the NIH\, Simons Foundation\, and NARSAD. Dr. Parker serves on the Editorial Board of Psychoneuroendocrinology\, and on various national (e.g.\, NIH and NSF) and international (e.g.\, Medical Research Council) grant review committees and scientific panels. \nDr. Parker was born in Boulder\, CO and grew up in suburban Chicago\, IL. She lives in the San Francisco Bay Area with her husband (a high-tech executive)\, three children\, and an Australian shepherd. \n  \n\n \nAccreditation Statement \nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statement: \nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Wisconsin–Madison ICEP\, as a member of the University Professional & Continuing Education Association (UPCEA)\, authorizes this program for 0.1 CEUs or 1.0 hour.
URL:https://www.psychiatry.wisc.edu/event/karen-j-parker-phd-uw-psychiatry-grand-rounds/
LOCATION:Webex
CATEGORIES:CME,Grand Rounds
ORGANIZER;CN="Jennifer Noll":MAILTO:jnoll3@wisc.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20190920T120000
DTEND;TZID=America/Chicago:20190920T130000
DTSTAMP:20260522T042933
CREATED:20190416T154030Z
LAST-MODIFIED:20190712T160850Z
UID:3624-1568980800-1568984400@www.psychiatry.wisc.edu
SUMMARY:Charles B. Nemeroff\, MD\, PhD | UW Psychiatry Grand Rounds
DESCRIPTION:Prediction of Disease Vulnerability and Treatment Response in Mood Disorders and PTSD: Personalized Medicine in Psychiatry \n\nFRIDAY SEPT 13 | 12:00pm\nWisPIC Commons Room 1616\n6001 Research Park Blvd \nCharles B. Nemeroff\, MD\, PhD\nChair and Professor of Psychiatry\nDirector\, Institute for Early Childhood Adversity Research\nUniversity of Texas at Austin – Dell Medical School \nLearning Objectives \n\nTo understand the principles of personalized medicine as applied to mood and anxiety disorders.\nTo understand the role of Genome Wide Association Studies (GWAS)\, candidate gene approaches\, transcriptomics\, epigenetics\, and proteomics in predicting disease treatment response in mood and anxiety disorders.\nTo understand the potential for functional brain imaging for predicting treatment response in mood and anxiety disorders.\nTo understand the role of gene-environment interactions\, particularly early life trauma\, in predicting treatment response in mood disorders.\n\n\nCharles B. Nemeroff\, MD\, PhD\, is a Professor of Psychiatry and Acting Chair of the Department of Psychiatry. He is also Associate Chair of Research\, and the Director of the Institute for of Early Life Adversity Research at Dell Medical School at the University of Texas at Austin. \nHe received his MD and PhD (Neurobiology) degrees from the University of North Carolina UNC) School of Medicine in Chapel Hill\, North Carolina. After psychiatry residency training at UNC and Duke University\, he held faculty positions at Duke University and was Chair of the Department of Psychiatry and Behavioral Sciences at Emory University for 18 years before relocating to the University of Miami in 2009. \nHe has served as President of the American College of Psychiatrists (ACP) and the American College of Neuropsychopharmacology (ACNP) and sits on the Scientific Advisory Board and Board of Directors of the American Foundation for Suicide Prevention (AFSP) and the Anxiety and Depression Association of America \n  \nHe has received a number of research and education awards including the Kempf Award in Psychobiology\, the Samuel Hibbs Award\, Research Mentoring Award\,Judson Marmot Award and the Vestermark Award from the American Psychiatric Association (APA)\, the Mood Disorders Award\, Bowis Award and Dean Award from the ACP and the Julius Axelrod Award for mentoring from the ACNP. He was elected to the Institute of Medicine (now the National Academy of Medicine) of the National Academy of Sciences in 2002. \nHe has been named Alumnus of the Year from the University of North Carolina (UNC) and from the UNC Medical School. He received the Doctorate Honoris Causa from Maimonides University in Buenos Aires in 2015. \nHis research has focused on the pathophysiology of mood and anxiety disorders with a focus on the role of child abuse and neglect as a major risk factor. He has also focused on the role of mood disorders as a risk factor for major medical disorders including heart disease\, diabetes and cancer. He has published more than 1100 research reports and reviews. \nHe has served on the Mental Health Advisory Council of NIMH and the Biomedical Research Council for NASA. He is the co-editor in chief (with Alan F. Schatzberg\, MD.) of the Textbook of Psychopharmacology\, published by the APA Press\, now in its Fifth Edition. \nHis research is currently supported by grants from the NIH.
URL:https://www.psychiatry.wisc.edu/event/grand-rounds-greenfield-speaker/
LOCATION:Webex
CATEGORIES:CME,Grand Rounds
ORGANIZER;CN="Jennifer Noll":MAILTO:jnoll3@wisc.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20190823T120000
DTEND;TZID=America/Chicago:20190823T131500
DTSTAMP:20260522T042933
CREATED:20190215T214254Z
LAST-MODIFIED:20190220T215220Z
UID:3515-1566561600-1566566100@www.psychiatry.wisc.edu
SUMMARY:Heather Abercrombie\, PhD | UW Psychiatry Grand Rounds
DESCRIPTION:Neurocognitive Sensitivity to Cortisol in Depression\n  \nHeather C. Abercrombie\, Ph.D.\nAssociate Professor (CHS)\nUniversity of Wisconsin-Madison\nSchool of Medicine and Public Health\nDepartment of Psychiatry \n\nMany individuals with depression show “glucocorticoid resistance\,” which reflects systemic and cellular insensitivity to the stress-related hormone cortisol.  However\, the neural and psychological relevance of glucocorticoid resistance is unknown. This is a huge gap in our knowledge\, because basic research shows that cortisol has potent yet variable effects on psychological function. Our research addresses this knowledge gap\, and we have shown that glucocorticoid resistance is related to negatively biased emotional memory and related neural circuitry. Importantly\, we have also shown that cortisol augmentation ameliorates negative memory bias in depression\, particularly in glucocorticoid resistant individuals. Taken together\, these findings suggest that glucocorticoid resistance is related to core psychological features of depression\, and that boosting cortisol signal may be psychologically beneficial in glucocorticoid resistant individuals with depression. \n  \nLearning objectives: \n\nDebunk popular notions of cortisol as unequivocally harmful\nUnderstand the relation between cortisol and psychological functions relevant to depression\nUnderstand that cortisol augmentation may be beneficial in depression\n\n\n \nAccreditation Statement \nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statement: \nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Wisconsin–Madison ICEP\, as a member of the University Professional & Continuing Education Association (UPCEA)\, authorizes this program for 0.1 CEUs or 1.0 hour.
URL:https://www.psychiatry.wisc.edu/event/heather-abercrombie-phd-uw-psychiatry-grand-rounds/
LOCATION:Webex
CATEGORIES:CME,Grand Rounds
ORGANIZER;CN="Jennifer Noll":MAILTO:jnoll3@wisc.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20190628T120000
DTEND;TZID=America/Chicago:20190628T131500
DTSTAMP:20260522T042933
CREATED:20190215T213540Z
LAST-MODIFIED:20190219T155141Z
UID:3511-1561723200-1561727700@www.psychiatry.wisc.edu
SUMMARY:Anna Ratzliff\, MD\, PhD | UW Psychiatry Grand Rounds
DESCRIPTION:Implementing Collaborative Care: Translation from Research to Real World\nAnna Ratzliff\, MD\, PhD\nAssociate Professor\nDepression Therapy Research Endowed Professorship\nDirector\, AIMS Center\nDirector\, UW Integrated Care Training Program \n  \nLearning Objectives:\n1)      List common barriers and facilitators to collaborative care implementation.\n2)      Describe five phases to implementation of collaborative care.\n3)      Name common factors influencing the sustainability of collaborative care. \nThis lecture will provide a brief overview of the collaborative care model (CoCM) and review current thinking about implementation of this approach to deliver mental health treatment in primary care settings.  An approach to the five phase of implementation will be discussed including common barriers and facilitators. \n\nDr. Anna Ratzliff is a national expert on collaborative care and specifically\, on training teams to implement and deliver mental health treatment in primary care settings. Her passion for translating complex research ideas into practical real-world applications began when she received her MD and PhD in Anatomy and Neurobiology as part of the Medical Scientist Training Program at the University of California at Irvine.  She currently is an Associate Professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington where she has developed expertise in suicide prevention training\, mental health workforce development\, adult learning best practices\, and mentorship. Dr. Ratzliff is the Director of the AIMS Center (Advancing Integrated Mental Health Solutions)\, is the Director of the UW Integrated Care Training Program for residents and fellows\, and leads a national collaborative care training program for the American Psychiatric Association’s Transforming Clinical Practices Initiative grant. For more information on collaborative care please visit the AIMS Center Website (aims.uw.edu)\, the UW Integrated Care Training Program (ictp.uw.edu). \n\n \nAccreditation Statement \nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statement: \nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Wisconsin–Madison ICEP\, as a member of the University Professional & Continuing Education Association (UPCEA)\, authorizes this program for 0.1 CEUs or 1.0 hour.
URL:https://www.psychiatry.wisc.edu/event/anna-ratzliff-md-phd-uw-psychiatry-grand-rounds/
LOCATION:Webex
CATEGORIES:CME,Grand Rounds
ATTACH;FMTTYPE=image/jpeg:https://www.psychiatry.wisc.edu/wp-content/uploads/2019/02/Anna-Ratzliff-2018.jpg
ORGANIZER;CN="Jennifer Noll":MAILTO:jnoll3@wisc.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20190419T120000
DTEND;TZID=America/Chicago:20190419T131500
DTSTAMP:20260522T042933
CREATED:20181120T184303Z
LAST-MODIFIED:20190228T210031Z
UID:3397-1555675200-1555679700@www.psychiatry.wisc.edu
SUMMARY:Boris Birmaher\, MD | UW Psychiatry Grand Rounds
DESCRIPTION:*** Part of the Briskey Family Bipolar Lecture Series*** \nPredicting the Development of Bipolar Disorder and Mood Recurrences –\nToward Personalized Psychiatry\nBoris Birmaher\, MD\nEndowed Chair in Early Onset Bipolar Disease and Professor of Psychiatry\nDirector\, Child and Adolescent Bipolar Spectrum Services\nCo-Director\, Psychiatry Research Pathway Program\nUniversity of Pittsburgh \nLearning objectives: \n\nTo describe the prodromal symptoms of bipolar disorder\nTo describe the course and outcome of bipolar disorder in youth and the factors associated with increases risk for recurrences\nTo describe the use of “risk calculators” to predict “personalized” risk to develop bipolar disorder as well as the risk of recurrences.\n\n\nDr. Birmaher is the Endowed Chair in Early Onset Bipolar Disease and Professor of Psychiatry at the University of Pittsburgh\, School of Medicine and serves as the Co-Director of the Psychiatry Research Pathway program and the Director of the Child and Adolescent Bipolar Spectrum Services.  He received his medical degree from Valle University in Cali\, Colombia; completed training in general psychiatry at the Hebrew University in Jerusalem\, Israel\, and child psychiatry at Columbia University\, New York. \nDr Birmaher is a leader in the study and treatment of pediatric mood and anxiety disorders. In addition\, his research has concentrated in describing the predictors\, risk factors\, course and treatment of childhood-onset bipolar disorder.  Throughout his career\, he has served as the Principal\, Co-Principal or co-investigator for over 25 federally-sponsored research grants and projects.  He has authored or co-authored more than 430 publications\, numerous book chapters as well as his own book\, New Hope for Children and Teens with Bipolar Disorder.  Dr. Birmaher has been the recipient of numerous awards over the years including the Colvin Prize for Outstanding Achievement in Mood Disorders Research in 2013 and the Ittleson Award for Research in Child and Adolescent Psychiatry in 2014.  In 2018\, he received the Gerald L Klerman Senior Investigator Award and the Lifelong Fellow Award from the American Psychiatric Association. For four years and until 10/2018 he was the Program Chair of the American Academy of Child and Adolescent Psychiatry and recently was named Counselor-At-Large of the same association. Through his research\, clinical and mentoring activities\, Dr. Birmaher has increased our understanding of the risk factors for mood and anxiety disorders\, developed and implemented innovative treatments to improve the lives of patients and their families\, and trained the next generation of educators\, clinicians and researchers. \n\n \nAccreditation Statement \nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statement: \nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Wisconsin–Madison ICEP\, as a member of the University Professional & Continuing Education Association (UPCEA)\, authorizes this program for 0.1 CEUs or 1.0 hour. \n 
URL:https://www.psychiatry.wisc.edu/event/boris-birmaher-md-uw-psychiatry-grand-rounds/
LOCATION:Webex
CATEGORIES:CME,Educational Conference (Park Street),Grand Rounds
ATTACH;FMTTYPE=image/jpeg:https://www.psychiatry.wisc.edu/wp-content/uploads/2018/11/Boris2017-1.jpg
ORGANIZER;CN="Jennifer Noll":MAILTO:jnoll3@wisc.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20190308T120000
DTEND;TZID=America/Chicago:20190308T131500
DTSTAMP:20260522T042933
CREATED:20190215T212132Z
LAST-MODIFIED:20190220T215057Z
UID:3501-1552046400-1552050900@www.psychiatry.wisc.edu
SUMMARY:Conor Liston\, MD\, PhD | UW Psychiatry Grand Rounds
DESCRIPTION:Neuroimaging Biomarkers for Diagnosing Neurophysiological Subtypes of Depression and Predicting Treatment Response\n  \nConor Liston\, MD\, PhD\nAssistant Professor of Neuroscience\nBrain and Mind Research Institute\nand Department of Psychiatry\nWeill Cornell Medicine \n\nConor Liston\, MD\, PhD is an Associate Professor of Neuroscience and Psychiatry in the Feil Family Brain and Mind Research Institute and the Department of Psychiatry at Weill Cornell Medicine. The long-term goals of his research program are to define mechanisms by which prefrontal cortical brain circuits support learning\, memory\, and motivation\, and to understand how these functions are disrupted in depression\, addictions\, and other stress-related psychiatric disorders. To this end\, experiments in his lab integrate optogenetic tools and genetically encoded calcium indicators with two-photon imaging and functional MRI\, and his team is actively developing new methods for quantifying prefrontal cortical microcircuit dynamics in genetically defined neuronal subtypes. They are also developing novel neuroimaging tools for informing psychiatric diagnosis in human populations and predicting treatment response to transcranial magnetic stimulation (TMS) and other neurostimulatory antidepressant interventions. \nDr. Liston graduated summa cum laude from Harvard College in 1998\, and received his PhD and MD from The Rockefeller University and Weill Cornell Medicine in 2007 and 2008\, respectively\, where he was supported by a Paul and Daisy Soros Fellowship for New Americans. He subsequently completed his residency in psychiatry at New York–Presbyterian Hospital and postdoctoral training at Stanford University. He returned to Weill Cornell as an Assistant Professor in 2014. His research has been recognized with awards from the Klingenstein-Simons Foundation Fund\, the Rita Allen Foundation\, the Dana Foundation\, the Doris Duke Charitable Foundation\, and the One Mind Institute. Dr. Liston is also a clinically active psychiatrist specializing in the management of treatment-resistant mood disorders. \n  \n\n \nAccreditation Statement \nIn support of improving patient care\, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. \nCredit Designation Statement: \nThe University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Wisconsin–Madison ICEP\, as a member of the University Professional & Continuing Education Association (UPCEA)\, authorizes this program for 0.1 CEUs or 1.0 hour.
URL:https://www.psychiatry.wisc.edu/event/conor-liston-md-phd-psychiatry-grand-rounds/
LOCATION:Webex
CATEGORIES:CME,Grand Rounds
ATTACH;FMTTYPE=image/jpeg:https://www.psychiatry.wisc.edu/wp-content/uploads/2019/02/Liston.jpeg
ORGANIZER;CN="Jennifer Noll":MAILTO:jnoll3@wisc.edu
END:VEVENT
END:VCALENDAR